CJC-1295 DAC dosage protocols leverage this long-acting growth hormone-releasing hormone (GHRH) analog’s unique albumin-binding technology, which extends its half-life to approximately 6–8 days[1][2]. By stimulating pulsatile growth hormone (GH) release while preserving natural GH rhythms, CJC-1295 DAC can elevate GH levels 2–10 fold and IGF-1 levels 1.5–3 fold in human studies[3]. Benefits may include enhanced muscle growth and recovery, improved fat metabolism, better sleep quality, and anti-aging effects through sustained GH/IGF-1 axis activation[4][5]. This educational protocol presents a once-weekly subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
- Reconstituir: Agregue 1.0 mL de agua bacteriostática → concentración de 2.0 mg/mL (2,000 mcg/mL).
- Dosis semanal típica: 2,000 mcg (2 mg) una vez a la semana - el vial completo por inyección.
- Medición fácil: A 2.0 mg/mL, 1 unidad = 0.01 mL = 20 mcg en una jeringa de insulina U-100; dosis completa = 100 unidades (1.00 mL).
- Almacenamiento: Liofilizado: congelar a −20 °C (−4 °F); después de la reconstitución, refrigerar a 2–8 °C (35.6–46.4 °F); evitar ciclos de congelación-descongelación.
